Increasing evidence suggests that glutamate neurotoxicity is partly mediated by reactive oxygen species, formed as a consequence of several processes, including arachidonic acid metabolism and nitric oxide production.
Here we used an oxidation-sensitive indicator, dihydrorhodamine 123, in combination with confocal microscopy, to examine the hypothesis that electron transport by neuronal mitochondria may be an important source of glutamate-induced reactive oxygen species (ROS). Exposure to NMDA, but not kainate, ionomycin, or elevated potassium stimulated oxygen radical production in cultured murine cortical neurons, demonstrated by oxidation of nonfluorescent dihydrorhodamine 123 to fluorescent rhodamine 123. Electron paramagnetic resonance spectroscopy studies using 5,5-dimethyl-1-pyrroline- N-oxide (DMPO) as a radical-trapping agent, also showed production of ROS by cortical neurons after NMDA but not kainate exposure.
NMDA-induced ROS production depended on extracellular Ca2+. and was not affected by inhibitors of nitric oxide synthase or arachidonic acid metabolism.
The increased production of ROS was was blocked by inhibitors of mitochondrial electron transport, rotenone or antimycin, and mimicked by the electron transport uncoupler, carbonyl cyanide p-trifluoromethoxyphenylhydrazone.
These data support the possibility that NMDA receptor-mediated, Ca*+-dependent uncoupling of neuronal mitochondrial electron transport may contribute to the oxidative stress initiated by glutamate exposure.
[Key words: glutamate, excitotoxicity, neurotoxicity, free radicals, mitochondria, dihydrorhodamine, oxidation, electron transport] Tissue damage produced by reactive oxygen species, such as hydrogen peroxide, and superoxide and hydroxyl radicals, has been implicated in the pathogenesis of both acute and chronic insults to the CNS. Markers of reactive oxygen species (ROS) production have been observed in animal models of traumatic brain (Kontos and Wei, 1986) and spinal cord injury (Saunders et al., 1987; Braughler and Hall, 1989) , and formation of ROS and loss of endogenous antioxidants has been documented during CNS ischemia-reperfusion (Flamm et al., 1978; Chan et al., 1985; Halliwell, 1989) . Further, antioxidant therapy is neuroprotective in trauma and ischemia (Saunders et al., 1987; Hall et al., 1988; Liu et al., 1989) . A potential role for ROS in certain neurodegenerative disorders has also been proposed (Sinet, 1982; Beal, 1992; Cleeter et al., 1992; Halliwell, 1992; Rosen et al., 1993 ; but see Gurney et al., 1994) .
Another pathological process that has been implicated in many of the same settings is glutamate receptor-mediated excitotoxicity. While excitotoxic and oxidative injury may occur independently, growing evidence indicates that ROS formation may also be a specific consequence of glutamate receptor activation, and may partly mediate excitotoxic neuronal damage (Choi, 1988; Coyle and Puttfarcken, 1993) . Exposure of cultured cerebellar granule cells to N-methyl-M-aspartate (NMDA) stimulates superoxide radical formation ( Lafon-Cazal et al., 1993) , and antioxidants can attenuate glutamate receptor-mediated neurotoxicity (Dykens et al., 1987; Chan et al., 1990; Monyer et al., 1990 , Yue et al., 1993 .
Glutamate receptor activation may lead to toxic ROS formation though several cellular processes initiated by N-methyl-Maspartate (NMDA) receptor activation and subsequent elevation of intracellular free calcium ([Ca"],) . Release of arachidonic acid by phospholipase A,, initially described in ischemia (Bazan, 1970; Chan and Fishman, 1978) , was subsequently linked to NMDA receptor activation (Dumuis et al., 1988) . Radicals generated during NMDA-stimulated metabolism of arachidonic acid (Dumuis et al., 1988; Rose et al., 1990; Rothman et al., 1993) may add to oxidative injury. More recently, nitric oxide, a free radical gas (Garthwaite et al., 1989) , has been suggested to contribute substantially to excitotoxic damage (Beckman et al., 1990; Dawson et al., 1991; Vincent and Hope, 1992) .
Another source of ROS that may be recruited under pathological conditions is the mitochondrial electron transport chain (Flamm et al., 1978; Halliwell, 1989; Beal, 1992) . Small inefficiencies in electron transport produce background levels of free radicals (Chance et al., 1979) . Calcium-dependent uncoupling of electron transport from ATP production in isolated mitochondria can result in substantial free radical formation (Chacon and Acosta, 1991; Dykens, 1994) . The important question whether this happens in intact neurons has been hard to address, given difficulties in detecting intracellular ROS production, and isolating a neuronal signal from that from other cell types.
The purpose of the present study was to test the specific hy- 
the complex III inhibitor antimycin A (1 pg/ml, added 30 min prior to NMDA): (7) 0 mM Ca*+ with 300 JLM EGTA; (8) 10 )LM (as a coapplication with NMDA); (9) glutamate 300 PM. All subsequent conditions included 10 pM (10) kainate 100 pM, (11) the metabotropic receptor agonist t-ACPD 300 pM, (12) KC1 60 mM, (13) ionomycin 3 pM, and (14) the mitochondrial uncoupler FCCP (3 FM), which included the AMPAikainate receptor antagonist NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quainaox~ine 10 pM) in addition to Values represent the change in fluorescence intensity as % of basal fluorescence, mean + SEM; n = the number of cells evaluated. Experiments involving NMDA were evaluated separately from experiments involving other agonists. *, p i 0.05 vs washed control, t, p < 0.05 vs NMDA, using repeated measures ANOVA and Bonferroni r test for multiple comparisons.
pothesis that mitochondria are important sources of ROS after glutamate receptor activation in intact cortical neurons. We used confocal microscopy and the oxidation-sensitive indicator, dihydrorhodamine 123, to measure mitochondrial ROS production. This lipophilic indicator can easily enter cells; when oxidized to the positively charged fluorescent derivative, rhodamine 123 (Henderson and Chappell, 1993; Royal1 and Ischoropoulos, 1993; Kooy et al., 19941 , it moves to the inside-negative (about -180 mV) mitochondrial environment (Johnson et al., 1980; Emaus et al., 1986) . Abstracts have appeared previously (Dugan, 1993; Dugan et al., 1994) .
Materials and Methods
Cell cultures. Neocortical cell cultures were prepared from fetal (E15) Swiss-Webster mice (Simonson) as described previously (Rose et al., 1993) . Cortical hemispheres were dissected away from the rest of the brain and placed in trypsin (0.25%, GIBCO) for 15 min. The cortices were briefly centrifuged, the trypsin was removed, and the hemispheres resuspended in plating medium, which consisted of media stock (Eagle's t Minimal Essential Media minus L-glutamine, GIBCO 11430-022) with 20 mu glucose, 26.2 ~IUVI NaHCO,), supplemented with L-glutamine (2 mu), 5% fetal calf serum, and 5% horse serum (Hyclone). After trituration, cell suspensions were diluted and plated onto a preexisting bed of mouse cortical astrocytes on 35 mm culture dishes (Mat-Tek) possessing an oval cut-out sealed by a glass coverslip. Cells were fed biweekly with growth medium (media stock with 10% horse serum, 2 mu L-glutamine), until the final feeding at day 11 or 12 in vitro, when cultures were fed with media stock supplemented with 2 mu L-glutamine. After 12-17 d in culture, cells were used for experiments.
Confocal microscopy. Cultures were washed into HEPES, bicarbonate-buffered balanced salt solution (HBBSS, containing, in mu, 116 NaCl, 5.4 KCl, 0.8 MgSO, , 1.8 NaPO, , 12 HEPES, 25 NaHCO, , 5 .5 D-glucose, pH 7.40 with 10 p,~ glycine). Dihydrorhodamine 123 (Molecular Probes, Eugene, OR) stock (10 111~) was made in DMSQ,.and stored at -20°C. Dilutions of this stock were used for 3-4 d of experiments. Stock solutions contained a small amount (< 1%) of contaminating rhodamine 123, as measured using a Perkin-Elmer LB50 Fluorescence Spectrometer. Cells incubated with dihydrorhodamine at 37°C in a 5% CO, incubator for 30 min prior to microscopy.
In cells loaded with dihydrorhodamine, cellular fluorescence was imaged using a laser scanning confocal microscope (Noran Odyssey), with an argon-ion laser coupled to an inverted microscope (Nikon Diaphot) equipped with a 60X oil-immersion objective (Nikon Plan Apo, N.A. 1.4). For dihydrorhodamine, excitation X was 488 nm, and fluorescence was monitored at X > 515 nm. For assessment of mitochondrial membrane potential by confocal microscopy, cultures were loaded with 0.5 p,M tetramethylrhodamine (Molecular Probes, excitation A = 529 n:n, emission A > 550 nm) for 30 min. The beam was attenuated to less than 5% of maximum illumination, and laser exposure was limited to brief image acquisition intervals (5 2 set every 4 min) using a computer-controlled shutter. These conditions for fluorescence microscopy were chosen from control experiments to minimize photo-oxidation of dihydrorhodamine, and laser settings and exposure duration were then held constant for all experiments. Frame-averaged confocal images were digitized at 512 X 480 or 640 X 480 pixels using microcomputer-based imaging software (MetaMorph, Universal Imaging). For analysis of fluorescence intensity over time, regions of interest were selected to included neuronal cytoplasm (excluding the nucleus); values reported here represent average pixel intensities within identified neurons. It was not practical to follow fluorescence intensities from individual mitochondria because of their small size and motion.
Drug application.
For all experiments, cells were maintained in the original solution containing dihydrorhodamine without further media exchange; all drugs were added by diluting drug with a small aliquot (50-100 ~1) of medium removed from the dish. Since dihydrorhodamine will equilibrate between the intracellular and extracellular compartments, this allowed us to maintain a steady-state intracellular concentration of dihydrorhodamine throughout the kxperiments (Royal1 and Ischoronoulos. 1993 ). Exposure to NMDA was initiated by addition of NMDA' to the culture dish, and was terminated after 5-min by the addition of 10 pM . Exposure to 60 mu KCl, 100 pM kainate, 300 JLM t-ACPD, 3 FM ionomycin or carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP; 3 PM) was done in the presence of 10 PM quinaoxaline, NBQX, 10 FM, in the case of FCCP). The kainate concentration chosen (100 pM X 30 min) produces near-complete loss of the total neuronal population within 24 hr (Koh et al., 1990) . A pretreatment period (30 min for rotenone and antimycin, 15 min for NG-L-Arginine) was included prior to application of NMDA for some experiments.
To determine Ca2+-dependence of dihydrorhodamine oxidation, cells were loaded with dihydrorhodamine, and cultures were then exchanged into HBBSS (containing 300 PM EGTA) without Caz+. The cells were maintained in zero CaZ+ for an additional 5 min after the 5 min exposure to NMDA, and then were replaced into Caz+-containing HBBSS.
Electron paramagnetic resonance (EPR) spectroscopy.
Cortical cultures were washed into HBBSS, and exposed to drugs in the presence of 100 mu 5, 5-dimethyl-1-pyrolline-N-oxide (DMPO, as the spin-trapping agent), and diethyltriaminopentaacetic acid (DETAPAC, a chelator) at room temperature. After exposure, the sample was rapidly transferred into a quartz flat cell (60 X 10 X 0.25 mm). EPR settings on the Bruker X-band spectrometer (ER200, Bruker, Billirica, MA) were: microwave power 1 .O mW, modulation amplitude 1 G, modulation frequency 100 Hz, R.G. 5 X 103. Signal intensity was determined as the height (cm) of the central hydroxyl radical peak on the up-field side of the midpoint. , and fluoresence was measured as described in Figure 1D . Values represent mean + SEM: NMDA with Caz+, n = 237 cells, 21 experiments, NMDA without Ca*+, n = 20, three experiments. The summary of statistical analyses of dihydrorhodamine data for this and subsequent figures is listed in Table 1. 1985). Neurons for intracellular CaZ+ imaging experiments were prepared as described, and experiments were performed on cultures between 12 and 17 d in vitro. Cells were loaded with 5 FM fora-AM (acetyxymethyl ester) plus 0.1% Pluronic F-127 for 30 min at room temperature, washed, and incubated for an additional 30 min in HBBSS. Experiments were performed at room temperature on the stage of a Nikon Diaohot inverted microscope equipped with a 75 W Xenon lamp and a Nikbn 40X, 1.3 N.A. epiAuor&ehce oil immersion objective. Fura-(Ex X = 340, 380 nm, Em A = 510 nm) ratio images were acquired with a CCD camera (Quantex), and digitized (256 X 512 pixels) using an Image-l system (Universal Imaging). Calibrated [Ca*+], values were obtained using the ratio method of Grynkiewicz et al. (1985) , by determining F,,, and F,, in situ using EGTA (10 mM) with 0 CaZ+ buffer and ionomycin (10 FM) for F,,,, and 10 mM CaZ+ with ionomycin (10 FM) for F,,. A Kd value of 225 nM Ca2+ was used for Fura-2.
Replication.
All experiments reported here represent at least three independent replications.
Results

Dihydrorhodamine oxidation and confocal imaging
Murine neocortical cultures were loaded with 5 pM dihydrorhodamine for 30 min and examined for fluorescence by confocal microscopy. A low level of fluorescence was present in neurons and glia at the end of the 30 min loading period (Figs. lB,C, t = 0). This background fluorescence reflected trace rhodamine 123 contamination of the dihydrorhodamine stock (see Materials and Methods), and did not change in untreated cultures over a period of at least 2 hr. Exposure of cultures to this concentration of dihydrorhodamine for 24 hr was not toxic, and did not potentiate NMDA toxicity, as determined by morphologic assessment of cultures and LDH efflux (not shown). (Fig. lB, t = 0) . This was followed by exposure of cells to 50-300 pM NMDA for 5 min, then addition of 10 pM to abolish further NMDA receptor activation. Figure 1D represents the dihydrorhodamine fluorescence response to 100 p,M NMDA exposure in a typical field of neurons. Such NMDA exposure induced a marked increase in fluorescence that was highly localized to presumptive mitochondria (Table 1, Fig. lB) , likely reflecting the oxidation of dihydrorhodamine to its fluorescent analog, rhodamine 123. Application of 300 pM glutamate also increased neuronal mitochondrial fluorescence (Table 1 ). The glial monolayer beneath the neurons shown in Fig. 1B exhibited no increase in mitochondrial fluorescence for the duration of the experimental protocol (Fig. 1C) . In contrast to the localized appearance of rhodamine 123 staining after NMDA, when dihydrorhodamineloaded cultures were exposed to exogenous ROS (30 mu H202), a gradual diffuse increase in fluorescence occurred over the entire cell (Fig. 2) , that required IO-15 min to become localized to mitochondria. Control experiments verified that sham wash or coapplication of MK-801 and NMDA failed to produce an increase in mitochondrial or cellular fluorescence, and coapplication of superoxide dismutase and catalase (100 U/ml each) to scavenge extracellular ROS failed to affect the fluorescence increase observed following NMDA.
The characteristic quenching of rhodamine 123 fluorescence as the concentration of dye in the membrane increases has been exploited for determination of mitochondrial membrane potential. Such quenching, however, might result in an underestimate of the amount of dihydrorhodamine oxidized, as the oxidation product, rhodamine 123 is taken up into mitochondria. Quenching is concentration dependent, and the amount of rhodamine 123 generated by oxidation of dihydrorhodamine in these experiments is much less the concentrations typically used for measurement of mitochondrial membrane potential. Further, 40-60 min after exposure to 300 pM NMDA, the mitochondrial fluorescence occasionally redistributed abruptly to the cytoplasm, consistent with loss of the mitochondrial membrane po toplasmic staining was seen after prolonged exposure to kainate sufficient to deporalize mitochondria.
Removal of external Ca'+ (in the presence of 300 pM EGTA) for the duration of NMDA exposure completely abolished the oxidative conversion of dihydrorhodamine to rhodamine 123 and the resultant increase in mitochondrial fluorescence intensity (Fig. 3) . In contrast to NMDA. kainate (100 pb~). KC1 (60 mh4). ionomycin (3 phlr) (Fig. 4) . and 1s. 3R-trans-l-aminocyclopentane-I .3-dicarboxylic acid (t-ACPD: 300 p.hl. a metabotropic glutamate receptor agonist (Table 1) . failed to generate any fluorescent signal (Table 1, Figs. 4, 5) . Each of these drugs were coapplied with 10 phr MK-801 to block any secondary activation of NMDA receptors through endogenous release of glutamate. Of note, kainate, ionomycin and high K-all elicited marked increases in cytosolic free Ca' . [Ca?+],. comparable to that induced by NMDA (Fig. 4) .
One potential explanation for the failure of kainate. ionomycin or high K-to result in enhanced rhodamine 123 fluorescence in mitochondria might be loss of the mitochondrial membrane potential, A*. resulting in dilution of mitochondrial rhodamine into the cytoplasmic and extracellular spaces. To verify that mitochondrial membrane potential remained intact for the duration of observation period used here (25-30 min). we loaded cells directly with the potentiometric dyes, tetramethylrhodamine methyl ester or rhodamine 123 itself (Johnson et al., 1980; Farkas et al.. 1989) . No loss of localized mitochondrial rhodamine 123 fluorescence was observed during application of kainate for 30 min (Fig. 6A) . ionomycin for 25 min (Fig. 6B) . FCCP for 60 min (not shovvn). or NMDA alone (not shoan). Tetramethylrhodamine gave similar results (not shown).  NBQX. NMDA. kainate. rotenone. and ionomycin showed no intrinsic fluorescence. and did not affect the rhodamine 123 fluorescence signal (not shown).
The ability of a toxic concentration of NMDA. but not kainate (Table 1 . Figs, 4C. 5). to elicit production of oxygen radicals is supported by results from EPR studies using 5.5dimethyl-1 -pyrroline- N-oxide (DMPO) as a spin trapping agent. Substantial production of a characteristic 'OH EPR signal (aN = aH, = 14.96 G) was detected after exposure of cultures to 300 khl NMDA for 20 min. but not 100 ~~11 kainate even after 2 hr of exposure (Fig. 7A) . The amount of extracellular 'OH detected for each experimental condition was quantified by measuring the height (in cm) of the second EPR peak from each spectrum. Results are shown graphically in 7B.
Plzannncology of ROS prodltction
Inhibition of two other sources of ROS generation (inhibition of nitric oxide formation by N"-L-Arginine, or arachidonic acid metabolism by the lipoxygenase/cyclooxygenase inhibitor meclofenamate) failed to abolish the increase in mitochondrial flu- orescence induced by NMDA receptor activation (Table 1) . However, addition of the mitochondrial electron transport uncoupler, carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (3 p,M, added together with 10 pM MK-801 and 10 pM 6,7-dintroquinoxaline-2,3-dione (NBQX) to block glutamate receptors) mimicked NMDA by inducing a marked increase in mitochondrial fluorescence (Fig. 8A,B) . Furthermore, inhibition of mitochondrial electron transport with Complex I or III inhibitors (rotenone, 10 FM and antimycin A, 1 p,g/ml, respectively) eliminated the NMDA-induced increase in ROS formation and resulting enhanced fluorescence (Fig. 9A ), without producing detectable changes in mitochondrial morphology or membrane potential, the latter assayed again by addition of rhodamine 123 itself (Fig. 9B) . However, the concentrations of rotenone or antimycin A used were sufficient to inhibit mitochondrial function and to result in a shift to glycolysis and lactate production (Behrens and Choi, unpublished data).
Discussion
The present study has two major findings: (1) exposure to NMDA, but not kainate, ionomycin, t-ACPD, or high K+, induced an increase in ROS levels in murine neocortical cultures, measured within neurons by the oxidation-sensitive probe, dihydrorhodamine, and in the bathing medium by EPR; and (2) this NMDA-induced ROS was blocked selectively by inhibitors of mitochondrial transport, but not by inhibitors of several other cellular pathways for radical generation. Both the appearance of increased fluorescence limited to mitochondria but not cytosol, and this latter pharmacology, argue for an important role of neuronal mitochondrial electron transport in producing ROS consequent to NMDA receptor activation. No evidence of glial ROS generation was detected by dihydrorhodamine in these experiments, even after kainate or high K+ exposure. Dihydrorhodamine is uncharged and rapidly loaded into cells (Royal1 and Ischoropoulos, 1993) ; it can be oxidized to rhodamine 123 by hydrogen peroxide in the presence of trace metals or peroxidase, or by peroxynitrite, but not by superoxide alone (Henderson and Chappell, 1993; Royal1 and Ischoropoulos, 1993; Kooy et al., 1994) . Rhodamine 123 is positively charged and lipophilic, and partitions over time to mitochondria because of their large inside-negative transmembrane potential, Aq. This mitochondrial localization has been used as an indicator of AlIr in isolated mitochondria or intact cells (Johnson et al., 1980; Emaus et al., 1986) . Oxidative conversion of dihydrorhodamine to rhodamine 123 has been used to detect ROS production by submitochondrial particles supplemented with NADH (Royal1 
T B Figure 7 . Electron paramagnetic resonance spectra (A) from cortical cultures exposed to NMDA (300 FM for 20 min), NMDA with MK-801 (10 PM), or kainate (100 PM with MK-801, 10 PM, for 2 hr), using 5,5-dimethyl-I-pyrroline-N-oxide (DMPO) as a spin-trapping agent. The exposure conditions for NMDA and kainate produce roughly similar levels of neuronal injury. A characteristic 'OH spectrum (1:2:2: l), indicated by the bracket, was observed after exposure of cultures to NMDA. Coapplication of MK-801 nearly abolished the signal induced by NMDA. In contrast, cultures exposed to kainate did not exhibit evidence of ROS formation. The amount of 'OH generated by cultures exposed to NMDA or kainate was estimated by measuring the peak height of the second peak of the spectrum obtained from each culture, shown graphically in B. Values are mean L SEM, *p < 0.05 versus washed control, **p < 0.05 versus NMDA alone, using ANOVA followed by Student-Newman-Keuls test for multiple comparisons; n for each condition is shown in parentheses.
and Ischoropoulos, 1993) as well as mitochondria isolated from rat cardiac myocytes (Chacon and Acosta, 1991) . A valuable characteristic of rhodamine 123 is that its fluorescence is not decreased by the intracellular acidification associated with glutamate receptor activation (Sensi et al., 1993; Irwin et al., 1994) . While it is possible that the mitochondrial fluorescent signal from dihydrorhodamine-loaded cells could serve as an indicator of ROS production anywhere in the cell, we showed that dihydrorohodamine-loaded cells exposed to H,O, exhibited generalized fluorescence from both mitochondria and cytoplasm, not the localized mitochondrial fluorescence induced by NMDA.
Selective linkage of central neuronal NMDA receptor activation to increased levels of ROS has also been found in two other studies. Lafon-Cazal et al. (1993) found that NMDA was more effective than kainate in inducing extracellular accumulation of ROS, detected by EPR, in cerebellar granule cell cultures. Contemporaneously with our study, Reynolds and Hastings have used the cytosolic oxidation-sensitive dye, 2,7-dichlorofluorescin diacetate, to detect ROS produced by rat forebrain neurons in response to glutamate agonists (Reynolds and Hastings, 1995) . Those authors found that glutamate, acting via the NMDA receptor in a Ca 2+-dependent manner, produced an increase in conversion of 2,7-dichlorofluorescin to the fluorescent species, 2,7-dichlorofluorescein, and that this conversion was blocked by depolarizing mitochondria using FCCP Their data are highly complementary with present data, and also led Reynolds and Hastings to the conclusion that mitochondria may be a key source of NMDA-induced ROS in central neurons. Their use of 2,7dichlorofluorescin has the advantage of providing insight into total cytosolic ROS levels not provided here; our use of dihydrorhodamine in the present paradigm has the advantage of providing subcellular information regarding real-time mitochondrial ROS formation.
We relied on the optical sectioning ability of the confocal microscope to establish the mitochondrial localization of rhodamine 123 fluorescence, and to demonstrate that the increased signal after NMDA exposure derived strictly from neuronal mitochondria. Inhibition of a potential nonmitochondrial source of neuronal ROS, nitric oxide synthase, had no effect on NMDAinduced ROS production. A mixed lipoxygenaselcyclooxygenase inhibitor, meclofenamate, which inhibits lipoxygenase and cyclooxygenase activities in our cortical cultures (Hewett, Dugan, and Choi, unpublished observations) was also ineffective in blocking NMDA-induced mitochondrial ROS production. Other inhibitors of eicosanoid formation (e.g., nordihydroguaiaretic acid or indomethacin) were not tested here because of the intrinsic free radical scavenging properties of these compounds (Dugan and Choi, unpublished observations) .
Further support for the idea that the rhodamine 123 fluorescence signal measured here reflects mitochondrial ROS generation is provided by pharmacological experiments using drugs that affect mitochondrial electron transport. FCCP an uncoupler of electron transport, mimicked the increase in rhodamine 123 fluorescence caused by NMDA, suggesting that uncoupling of mitochondrial electron transport is sufficient to produce ROS and dihydrorhodamine oxidation. While FCCP and similar protonophores (e.g., CCCP) are frequently used to eliminate the mitochondrial proton gradient, the uncoupling produced by these protonophores is concentration dependent (Heytler, 198 1; Ligeti and Lukacs, 1984; Yagi et al., 1984) , so that partial uncoupling of mitochondrial electron transport can be achieved with intermediate drug concentrations. The concentration employed for Table 1 . Bar = 20 km. the present studies (3 kbi), which was chosen specifically to preserve the mitochondrial membrane potential for the duration of the present experiments, did eventually result in mitochondrial depolarization later on. It is likely that the proton gradient, after application of FCCP, is supported initially by ATP hydrolysis and proton pumping by the F$,-ATPase, i.e., by reversal of the normal ATP production by mitochondrial F,F,-ATPase (Mitchell and Moyle, 1968). In other studies, micromolar concentrations of FCCP depolarized mitochondria quickly; we attribute the more delayed effect observed here to our inclusion of and NBQX in the exposure solution (if these were omitted, rapid 1055 of mitochondrial fluorescence/membrane potential occurred).
We speculated that mitochondria might be a source of ROS formation induced by NMDA. ac well. so we included inhibitors of electron transport during NMDA exposure to determine if dihydrorhodamine oxidation was blocked. Figure 9 . Mitochondrial electron transport inhibitors abolish mitochondrial ROS production after exposure to NMDA. Cells were pretreated with rotenone (10 PM X 30 min, A-A), or antimycin A (1 mg/ml X 30 min, O-O) prior to NMDA exposure. The curve for NMDA exposure alone (from Fig. 1D ) is included for reference. Mean + SEM for 31 cells from three experiments for antimycin A, and 40 cells from four experiments for rotenone. There was no loss of mitochondrial membrane potential for the duration of the experiment. Cells were loaded with rhodamine 123 and mitochondrial membrane potential was evaluated either as the average fluorescence intensity of the cell body, or in individual mitochondria (arrow). Higher concentrations of rotenone generally resulted in rapid loss of membrane potential after application of NMDA.
hibits electron transport through complex III, also blocked the high potassium all failed to induce mitochondrial ROS formafluorescence increase observed after NMDA exposure.
tion, despite being highly effective in raising [Caz+] ,. While fur-NMDA receptor activation likely induces neuronal mitochonther studies will be needed to define the basis for this difference, drial ROS formation via excess Ca*+ entry and consequent celit is consistent with the more powerful cytotoxicity of NMDA lular Ca*+ overload, as ROS formation was dependent on the receptor activation compared to AMPAikainate receptor activapresence of extracellular Ca2+ (see Reynolds and Hastings, tion or depolarization (Choi, 1988; Hartley and Dubinsky, 1993; . It is noteworthy that exposure to kainate, ionomycin, or Tymianski, 1993) . Although the latter are comparable to NMDA receptor activation in terms of inducing acute elevations in [CaZ+] , (Murphy and Miller, 1988; Michaels and Rothman, 1990; Miller, 1991) , NMDA receptors induce higher levels of net Ca2+ influx into neurons (Hartley and Dubinsky, 1993) , and induce a special late rise in intracellular free [Ca2+li (Manev et al., 1989; Tymianski et al., 1993; White and Reynolds, 1995) . The special ability of NMDA receptor stimulation to induce Ca*+ loading and cytotoxicity likely reflects, at least in part, the higher Ca*+ permeability of the NMDA receptor-gated channel relative to most AMPA or kainate receptor-gated channels (MacDermott et al., 1986) . However, the selective Ca2+ . ionophore ionomycin failed to mimic NMDA in stimulating mitochondrial ROS generation. Although ionomycin provides a ready route for Ca*+ influx, it is conceivable that NMDA receptor-gated channels mediate higher levels of net Ca2+ entry in the experimental period studied here. NMDA receptor-gated channels permit Nat entry as well as Ca*+ entry, thus triggering additional Ca*+ influx via routes such as voltage-gated calcium channels and the Na+/Ca*+ exchanger (Choi, 1987; Miller, 1991; Kiedrewski et al., 1994; White and Reynolds, 1995) . Indeed, activation of NMDA but not AMPA/ kainate receptors stimulates the Na+/Ca*+ exchanger, resulting in enhanced activity of the Ca*+-dependent phospholipase A, in striatal neurons (Dumuis et al., 1988 (Dumuis et al., , 1993 . Other possibilities, for example, a special spatial distribution of NMDA receptor channels on neurons relative to nonselective distribution of ionomycin, can also be considered.
NMDA receptor-induced activation of phospholipase A, may be a specific mediator of mitochondrial ROS production. It results in the release of free fatty acids, which uncouple mitochondrial electron transport (Wotjtczack, 1976; Hillered and Chan, 1988) . Another specific link between NMDA receptor activation and mitochondrial ROS production may be enhanced cellular ATP depletion, due to NMDA receptor-mediated Na+ loading and increased membrane Na+, K+-ATPase activity. Cellular ATP depletion is likely to lead to increased mitochondrial respiratory activity and thus increased mitochondrial ROS production.
Sustained elevation of [Ca2+lr, besides promoting mitochondrial ROS formation, may also be responsible for the late sudden loss of mitochondrial membrane potential sometimes observed 40-60 min after exposure to high concentrations of NMDA. A similar event was observed by Mattson et al. (1993) , 4 hr after exposure of hippocampal neurons to glutamate. This loss of mitochondrial membrane potential may reflect the Ca*+-dependent opening of an inner membrane pore (Gunter et al., 1994) , or mitochondrial damage. A particularly vulnerable target may be complex I, the main entry point of electrons into the electron transport chain. In isolated mitochondria, complex I is specifically inhibited by ROS in the presence of elevated Ca2+ (Malis and Bonventre, 1985; Dykens, 1994) .
Production of ROS by neuronal mitochondrial would be expected to have adverse effects on many aspects of neuronal cell functions. In particular, local damage could impair mitochondrial energy production, enhancing depletion of cellular energy stores, and leading to the impairment of myriad homeostatic or protective mechanisms. In addition, mitochondrial ROS production might deplete cellular antioxidant defenses, leading to more global enhancement of oxidative stress and radical-mediated injury throughout the cell. Mitochondrial ROS production may thus be key event in the cascade of events leading to neuronal injury after excitotoxic NMDA receptor activation.
